Skip to content

Effect of Added Varnum Mouthpiece on Pharyngeal Collapsibility and Sleep Apnea Severity in Mouth Breathers.

Effect of Added Varnum Mouthpiece on Pharyngeal Collapsibility and Sleep Apnea Severity in Mouth Breathers.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02738255
Enrollment
26
Registered
2016-04-14
Start date
2016-06-02
Completion date
2017-06-15
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

Obstructive sleep apnea, Mouth breathing, Apnea-Hypopnea Index (AHI)

Brief summary

Test the effect of added a single-use Varnum mouthpiece on pharyngeal collapsibility and obstructive sleep apnea (OSA) severity in patients who identify themselves as mouth breathers. Research indicates that nasal breathing not only may improve sleep apnea but it also increases circulation, blood oxygen, and carbon dioxide levels, slows the breathing rate, and improves overall lung volumes. Thus, the investigators will test whether a single-use Varnum mouthpiece can improve pharyngeal collapsibility and OSA severity in mouth breathers.

Detailed description

Obstructive sleep apnea (OSA) is a common disorder that remains under-treated due few therapeutic options beyond continuous positive airway pressure (CPAP). In patients with OSA, upper airway obstruction is caused by collapse of pharyngeal structures during sleep. It is known that mouth breathing increases upper-airway collapsibility during sleep and may contribute to the occurrence of sleep disordered breathing. In addition, it was shown that patients with a high percentage of mouth breathing during sleep were less adherent to CPAP therapy. Therefore, one potential solution to these problems is to use Varnum's mouthpiece to prevent mouth breathing during sleep. The overall objective of the current study is to improve upper airway collapsibility and sleep apnea in OSA patients who have a high percentage of mouth breathing during sleep. The investigators' central hypothesis is that preventing the lips from parting with the Varnum device will reduce oral breathing and thereby OSA severity in mouth breathers. The investigators chose this hypothesis because taping the mouth closed with a simple device such as the Varnum mouthpiece is the most straightforward approach to dealing with this common problem. With this research, it could become possible to overcome one of the major problems contributing to sleep apnea - mouth breathing. Therefore, the investigators aim to test the effect of the Varnum mouthpiece on pharyngeal collapsibility and OSA severity in patients who identify themselves as mouth breathers. The investigators' working hypothesis is that the device will keep the lips from separating and thereby prevent oral breathing. In doing so, it may help keep the airway more patent (by promoting nasal instead of oral breathing) in self-described mouth breathers and thus reduce OSA severity. On the contrary, the investigators believe patients who do not identify themselves as mouth breathers might not benefit significantly from the Varnum device. The expected outcome of this study is validation of new device for improving sleep apnea in a large subgroup of easily identifiable OSA patients, namely self-described mouth breathers. Such a device could advance the field by providing more effective alternative treatments.

Interventions

DEVICEVarnum mouthpiece

An adhesive mouthpiece with a central opening applied during sleep

Sponsors

David Andrew Wellman
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Presence of obstructive sleep apnea (AHI\>10 events/hr)

Exclusion criteria

* Serious co-morbidities including lung disease, heart disease, renal disease * Medications affecting respiration or sleep Mouth breather subgroup inclusion criteria: self-described mouth breathing habit during sleep. non-mouth breathing subgroup inclusion criteria: absence of self-described mouth breathing during sleep

Design outcomes

Primary

MeasureTime frameDescription
Sleep Apnea Severity as Measured by Apnea-hypopnea Index (AHI)Two nights: night with Varnum mouthpiece and night without Varnum mouthpieceThe number of respiratory events (apneas and hypopneas) per hour of sleep. This was measured on two nights in random order (night with Varnum mouthpiece and night without Varnum mouthpiece). The median AHI on the night with Varnum mouthpiece was then compared with median AHI on the night without Varnum mouthpiece.

Secondary

MeasureTime frameDescription
Pharyngeal Collapsibility as Measured by Median Peak Inspiratory Flow During SleepTwo nights: night with Varnum mouthpiece and night without Varnum mouthpieceThe median peak flow during sleep was measured and compared on both nights (night with Varnum mouthpiece and night without Varnum mouthpiece). The median peak flow is a surrogate measure of upper airway collapsibility.
Snoring Index in Simple SnorersTwo nights: night with Varnum mouthpiece and night without Varnum mouthpieceSnoring index is the number of breaths with snoring per hour of sleep. This was measured in both nights (night with Varnum mouthpiece and night without Varnum mouthpiece) only in simple snorers with AHI\<10. The median of snoring index was compared between night with Varnum mouthpiece and night without Varnum mouthpiece.

Countries

United States

Participant flow

Participants by arm

ArmCount
Polysomnogram With Varnum First, Regular Polysomnogram Second
Varnum mouthpiece, similar to a mouth tape with central opening on the first night, then a 1-week non-treatment period, then overnight sleep study with no mouthpiece.
11
Regular Polysomnogram First, Polysomnogram With Varnum Second
Baseline sleep study without Varnum mouthpiece on the first night, then a 1-week non-treatment period, then an overnight sleep study with Varnum mouthpiece on the second night.
15
Total26

Baseline characteristics

CharacteristicPolysomnogram With Varnum First, Regular Polysomnogram SecondRegular Polysomnogram First, Polysomnogram With Varnum SecondTotal
Age, Continuous54.2 years
STANDARD_DEVIATION 13.4
55.3 years
STANDARD_DEVIATION 8.1
54.8 years
STANDARD_DEVIATION 10.4
Apnea-Hypopnea Index17.0 Events/hour
STANDARD_DEVIATION 14.3
25.5 Events/hour
STANDARD_DEVIATION 18.1
21.9 Events/hour
STANDARD_DEVIATION 16.8
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Black or African American
3 Participants4 Participants7 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
7 Participants11 Participants18 Participants
Region of Enrollment
United States
11 participants15 participants26 participants
Sex: Female, Male
Female
2 Participants9 Participants11 Participants
Sex: Female, Male
Male
9 Participants6 Participants15 Participants
Snoring Index36.0 Events/hour
STANDARD_DEVIATION 57.9
331.2 Events/hour
STANDARD_DEVIATION 271.7
146.7 Events/hour
STANDARD_DEVIATION 215.3

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 260 / 26
other
Total, other adverse events
0 / 260 / 26
serious
Total, serious adverse events
0 / 260 / 26

Outcome results

Primary

Sleep Apnea Severity as Measured by Apnea-hypopnea Index (AHI)

The number of respiratory events (apneas and hypopneas) per hour of sleep. This was measured on two nights in random order (night with Varnum mouthpiece and night without Varnum mouthpiece). The median AHI on the night with Varnum mouthpiece was then compared with median AHI on the night without Varnum mouthpiece.

Time frame: Two nights: night with Varnum mouthpiece and night without Varnum mouthpiece

ArmMeasureValue (MEDIAN)
Polysomnogram With Varnum MouthpieceSleep Apnea Severity as Measured by Apnea-hypopnea Index (AHI)16.4 Events/hour
Regular PolysomnogramSleep Apnea Severity as Measured by Apnea-hypopnea Index (AHI)15.8 Events/hour
Secondary

Pharyngeal Collapsibility as Measured by Median Peak Inspiratory Flow During Sleep

The median peak flow during sleep was measured and compared on both nights (night with Varnum mouthpiece and night without Varnum mouthpiece). The median peak flow is a surrogate measure of upper airway collapsibility.

Time frame: Two nights: night with Varnum mouthpiece and night without Varnum mouthpiece

ArmMeasureValue (MEDIAN)
Polysomnogram With Varnum MouthpiecePharyngeal Collapsibility as Measured by Median Peak Inspiratory Flow During Sleep0.32 L/s
Regular PolysomnogramPharyngeal Collapsibility as Measured by Median Peak Inspiratory Flow During Sleep0.36 L/s
Secondary

Snoring Index in Simple Snorers

Snoring index is the number of breaths with snoring per hour of sleep. This was measured in both nights (night with Varnum mouthpiece and night without Varnum mouthpiece) only in simple snorers with AHI\<10. The median of snoring index was compared between night with Varnum mouthpiece and night without Varnum mouthpiece.

Time frame: Two nights: night with Varnum mouthpiece and night without Varnum mouthpiece

Population: This outcome was only calculated for simple snorers with AHI\<10 events/hour.

ArmMeasureValue (MEDIAN)
Polysomnogram With Varnum MouthpieceSnoring Index in Simple Snorers3.0 Snore/hour
Regular PolysomnogramSnoring Index in Simple Snorers30.4 Snore/hour

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026